GB0623750D0 - Substituted quinazolines - Google Patents

Substituted quinazolines

Info

Publication number
GB0623750D0
GB0623750D0 GBGB0623750.7A GB0623750A GB0623750D0 GB 0623750 D0 GB0623750 D0 GB 0623750D0 GB 0623750 A GB0623750 A GB 0623750A GB 0623750 D0 GB0623750 D0 GB 0623750D0
Authority
GB
United Kingdom
Prior art keywords
substituted quinazolines
quinazolines
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0623750.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire LLC
Original Assignee
Shire LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire LLC filed Critical Shire LLC
Priority to GBGB0623750.7A priority Critical patent/GB0623750D0/en
Publication of GB0623750D0 publication Critical patent/GB0623750D0/en
Priority to KR1020097011682A priority patent/KR20090094268A/ko
Priority to JP2009538792A priority patent/JP2010511030A/ja
Priority to CA002670123A priority patent/CA2670123A1/fr
Priority to MX2009005579A priority patent/MX2009005579A/es
Priority to BRPI0719570-2A priority patent/BRPI0719570A2/pt
Priority to AU2007327047A priority patent/AU2007327047B2/en
Priority to EA200900740A priority patent/EA018259B1/ru
Priority to CN2007800442429A priority patent/CN101558071B/zh
Priority to PCT/GB2007/050697 priority patent/WO2008065444A2/fr
Priority to EP07824909A priority patent/EP2099802A2/fr
Priority to TW096145020A priority patent/TW200838537A/zh
Priority to ARP070105272A priority patent/AR064002A1/es
Priority to IL198809A priority patent/IL198809A0/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB0623750.7A 2006-11-28 2006-11-28 Substituted quinazolines Ceased GB0623750D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB0623750.7A GB0623750D0 (en) 2006-11-28 2006-11-28 Substituted quinazolines
EP07824909A EP2099802A2 (fr) 2006-11-28 2007-11-19 Quinazolines substituées
AU2007327047A AU2007327047B2 (en) 2006-11-28 2007-11-19 Substituted quinazolines
CN2007800442429A CN101558071B (zh) 2006-11-28 2007-11-19 取代喹唑啉
CA002670123A CA2670123A1 (fr) 2006-11-28 2007-11-19 Quinazolines substituees
MX2009005579A MX2009005579A (es) 2006-11-28 2007-11-19 Quinazolinas sustituidas.
BRPI0719570-2A BRPI0719570A2 (pt) 2006-11-28 2007-11-19 Quinazolinas substituídas
KR1020097011682A KR20090094268A (ko) 2006-11-28 2007-11-19 치환된 퀴나졸린
EA200900740A EA018259B1 (ru) 2006-11-28 2007-11-19 Замещенные хиназолины
JP2009538792A JP2010511030A (ja) 2006-11-28 2007-11-19 置換キナゾリン類
PCT/GB2007/050697 WO2008065444A2 (fr) 2006-11-28 2007-11-19 Quinazolines substituées
TW096145020A TW200838537A (en) 2006-11-28 2007-11-27 Substituted quinazolines
ARP070105272A AR064002A1 (es) 2006-11-28 2007-11-28 Quinazolinas sustituidas
IL198809A IL198809A0 (en) 2006-11-28 2009-05-19 Substituted quinazolines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0623750.7A GB0623750D0 (en) 2006-11-28 2006-11-28 Substituted quinazolines

Publications (1)

Publication Number Publication Date
GB0623750D0 true GB0623750D0 (en) 2007-01-10

Family

ID=37671460

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0623750.7A Ceased GB0623750D0 (en) 2006-11-28 2006-11-28 Substituted quinazolines

Country Status (14)

Country Link
EP (1) EP2099802A2 (fr)
JP (1) JP2010511030A (fr)
KR (1) KR20090094268A (fr)
CN (1) CN101558071B (fr)
AR (1) AR064002A1 (fr)
AU (1) AU2007327047B2 (fr)
BR (1) BRPI0719570A2 (fr)
CA (1) CA2670123A1 (fr)
EA (1) EA018259B1 (fr)
GB (1) GB0623750D0 (fr)
IL (1) IL198809A0 (fr)
MX (1) MX2009005579A (fr)
TW (1) TW200838537A (fr)
WO (1) WO2008065444A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB2460915B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
GB0822970D0 (en) 2008-12-17 2009-01-21 Shire Llc Process for the preparation of anagrelide and analogues
GB201004495D0 (en) 2010-03-18 2010-05-05 Shire Llc Subtituted quinazolines
GB201017783D0 (en) 2010-10-21 2010-12-01 Shire Llc Process for the preparation of anagrelide and analogues thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
CA1131631A (fr) * 1979-06-20 1982-09-14 Madhukar S. Chodnekar Derives de la quinazoline et preparations pharmaceutiques
ZA803535B (en) * 1979-06-20 1981-06-24 Hoffmann La Roche Novel quinazoline derivatives and pharmaceutical preparations
US20040209907A1 (en) * 2003-01-23 2004-10-21 Richard Franklin Formulation and methods for the treatment of thrombocythemia
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors

Also Published As

Publication number Publication date
WO2008065444A2 (fr) 2008-06-05
EA018259B1 (ru) 2013-06-28
AU2007327047B2 (en) 2012-08-30
IL198809A0 (en) 2010-02-17
BRPI0719570A2 (pt) 2013-12-10
CN101558071B (zh) 2013-04-24
WO2008065444A3 (fr) 2008-07-31
MX2009005579A (es) 2009-08-12
CN101558071A (zh) 2009-10-14
CA2670123A1 (fr) 2008-06-05
EP2099802A2 (fr) 2009-09-16
EA200900740A1 (ru) 2010-02-26
TW200838537A (en) 2008-10-01
WO2008065444B1 (fr) 2008-10-09
AR064002A1 (es) 2009-03-04
AU2007327047A1 (en) 2008-06-05
JP2010511030A (ja) 2010-04-08
KR20090094268A (ko) 2009-09-04

Similar Documents

Publication Publication Date Title
DE602007002700D1 (en) Interventionsfreies frac-system
EP2078282A4 (fr) Coupons électroniques
EP2033216A4 (fr) Électroadhérence
DE602007008085D1 (en) Dihydropyrazolopyrimidinonderivate
DE602007014031D1 (en) Luftreifensatz
DE602007002070D1 (en) 2-pyrazincarboxamidderivate
PL1849352T3 (pl) Kombajn
DE602007003855D1 (en) Isothermer reaktor
EP1983992A4 (fr) 2-imino-benzimidazoles
DE602007001601D1 (en) Glasuntersuchung
IL192799A0 (en) Substituted 4-phenylpiperidines
DE602007006989D1 (en) Spiropiperidinderivate
ZA201008177B (en) Substituted quinazolines
HK1132994A1 (en) Mtki quinazoline derivatives mtki
IL198809A0 (en) Substituted quinazolines
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
DE602007011622D1 (en) Penem-prodrugs
EP2050739A4 (fr) Dérivé quinazoline
EP2084019A4 (fr) Grattoir a peinture
GB0808944D0 (en) Substituted quinazolines
GB0808947D0 (en) Substituted quinazolines
EP2024567A4 (fr) Papier peint à base de terre
GB0623749D0 (en) Substituted quinazolines
ZA200903382B (en) Substituted 4-imidazoles
GB0808950D0 (en) Substituted quinazolines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)